These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 16698420

  • 1. Genetic variation in IL-8 associated with increased risk and poor prognosis of breast carcinoma.
    Snoussi K, Mahfoudh W, Bouaouina N, Ahmed SB, Helal AN, Chouchane L.
    Hum Immunol; 2006; 67(1-2):13-21. PubMed ID: 16698420
    [Abstract] [Full Text] [Related]

  • 2. Genetic variation in pro-inflammatory cytokines (interleukin-1beta, interleukin-1alpha and interleukin-6) associated with the aggressive forms, survival, and relapse prediction of breast carcinoma.
    Snoussi K, Strosberg AD, Bouaouina N, Ben Ahmed S, Chouchane L.
    Eur Cytokine Netw; 2005 Dec; 16(4):253-60. PubMed ID: 16464738
    [Abstract] [Full Text] [Related]

  • 3. Association of IL-8 (-251)T/A polymorphism with susceptibility to and aggressiveness of nasopharyngeal carcinoma.
    Ben Nasr H, Chahed K, Mestiri S, Bouaouina N, Snoussi K, Chouchane L.
    Hum Immunol; 2007 Sep; 68(9):761-9. PubMed ID: 17869651
    [Abstract] [Full Text] [Related]

  • 4. Matrix metalloproteinase-1 (-1607) 1G/2G and -9 (-1562) C/T promoter polymorphisms: susceptibility and prognostic implications in nasopharyngeal carcinomas.
    Nasr HB, Mestiri S, Chahed K, Bouaouina N, Gabbouj S, Jalbout M, Chouchane L.
    Clin Chim Acta; 2007 Sep; 384(1-2):57-63. PubMed ID: 17599818
    [Abstract] [Full Text] [Related]

  • 5. A functional polymorphism of the tumor necrosis factor receptor-II gene associated with the survival and relapse prediction of breast carcinoma.
    Mestiri S, Bouaouina N, Ben Ahmed S, Chouchane L.
    Cytokine; 2005 May 21; 30(4):182-7. PubMed ID: 15863392
    [Abstract] [Full Text] [Related]

  • 6. Combined effects of IL-8 and CXCR2 gene polymorphisms on breast cancer susceptibility and aggressiveness.
    Snoussi K, Mahfoudh W, Bouaouina N, Fekih M, Khairi H, Helal AN, Chouchane L.
    BMC Cancer; 2010 Jun 12; 10():283. PubMed ID: 20540789
    [Abstract] [Full Text] [Related]

  • 7. P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer.
    Naidu R, Har YC, Taib NA.
    J Exp Clin Cancer Res; 2007 Mar 12; 26(1):133-40. PubMed ID: 17550142
    [Abstract] [Full Text] [Related]

  • 8. Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk.
    Langsenlehner U, Krippl P, Renner W, Yazdani-Biuki B, Eder T, Köppel H, Wascher TC, Paulweber B, Samonigg H.
    Breast Cancer Res Treat; 2005 Mar 12; 90(2):113-5. PubMed ID: 15803357
    [Abstract] [Full Text] [Related]

  • 9. Functional vascular endothelial growth factor -2578 C/A polymorphism in relation to nasopharyngeal carcinoma risk and tumor progression.
    Nasr HB, Chahed K, Bouaouina N, Chouchane L.
    Clin Chim Acta; 2008 Sep 12; 395(1-2):124-9. PubMed ID: 18588866
    [Abstract] [Full Text] [Related]

  • 10. A single nucleotide polymorphism in the matrix metalloproteinase-1 and interleukin-8 gene promoter predicts poor prognosis in tongue cancer.
    Shimizu Y, Kondo S, Shirai A, Furukawa M, Yoshizaki T.
    Auris Nasus Larynx; 2008 Sep 12; 35(3):381-9. PubMed ID: 18276095
    [Abstract] [Full Text] [Related]

  • 11. Association of interleukin-8 (IL-8 or CXCL8) -251T/A and CXCR2 +1208C/T gene polymorphisms with breast cancer.
    Kamali-Sarvestani E, Aliparasti MR, Atefi S.
    Neoplasma; 2007 Sep 12; 54(6):484-9. PubMed ID: 17949231
    [Abstract] [Full Text] [Related]

  • 12. Molecular screening of interleukin-6 gene promoter and influence of -174G/C polymorphism on breast cancer.
    Chérel M, Campion L, Bézieau S, Campone M, Charrier J, Gaschet J, Ricolleau G, Gouraud W, Charbonnel C, Jézéquel P.
    Cytokine; 2009 Sep 12; 47(3):214-23. PubMed ID: 19640729
    [Abstract] [Full Text] [Related]

  • 13. Interleukin-10 gene promoter polymorphisms and the risk of nasopharyngeal carcinoma.
    Wei YS, Kuang XH, Zhu YH, Liang WB, Yang ZH, Tai SH, Zhao Y, Zhang L.
    Tissue Antigens; 2007 Jul 12; 70(1):12-7. PubMed ID: 17559576
    [Abstract] [Full Text] [Related]

  • 14. Functional IL-18 promoter gene polymorphisms in Tunisian nasopharyngeal carcinoma patients.
    Farhat K, Hassen E, Bouzgarrou N, Gabbouj S, Bouaouina N, Chouchane L.
    Cytokine; 2008 Aug 12; 43(2):132-7. PubMed ID: 18555694
    [Abstract] [Full Text] [Related]

  • 15. A polymorphism C3435T of the MDR-1 gene associated with smoking or high body mass index increases the risk of sporadic breast cancer in women.
    Zubor P, Lasabova Z, Hatok J, Stanclova A, Danko J.
    Oncol Rep; 2007 Jul 12; 18(1):211-7. PubMed ID: 17549370
    [Abstract] [Full Text] [Related]

  • 16. The AA genotype of the regulatory BCL2 promoter polymorphism ( 938C>A) is associated with a favorable outcome in lymph node negative invasive breast cancer patients.
    Bachmann HS, Otterbach F, Callies R, Nückel H, Bau M, Schmid KW, Siffert W, Kimmig R.
    Clin Cancer Res; 2007 Oct 01; 13(19):5790-7. PubMed ID: 17908970
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of predictive and prognostic significance of serum TGF-beta1 levels in breast cancer according to HER-2 codon 655 polymorphism.
    Papadopoulou E, Anagnostopoulos K, Tripsianis G, Tentes I, Kakolyris S, Galazios G, Sivridis E, Simopoulos K, Kortsaris A.
    Neoplasma; 2008 Oct 01; 55(3):229-38. PubMed ID: 18348656
    [Abstract] [Full Text] [Related]

  • 18. The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation.
    Veeck J, Chorovicer M, Naami A, Breuer E, Zafrakas M, Bektas N, Dürst M, Kristiansen G, Wild PJ, Hartmann A, Knuechel R, Dahl E.
    Oncogene; 2008 Jan 31; 27(6):865-76. PubMed ID: 17653090
    [Abstract] [Full Text] [Related]

  • 19. FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer.
    Thussbas C, Nahrig J, Streit S, Bange J, Kriner M, Kates R, Ulm K, Kiechle M, Hoefler H, Ullrich A, Harbeck N.
    J Clin Oncol; 2006 Aug 10; 24(23):3747-55. PubMed ID: 16822847
    [Abstract] [Full Text] [Related]

  • 20. Tumor susceptibility and prognosis of breast cancer associated with the G870A polymorphism of CCND1.
    Yu CP, Yu JC, Sun CA, Tzao C, Ho JY, Yen AM.
    Breast Cancer Res Treat; 2008 Jan 10; 107(1):95-102. PubMed ID: 18043898
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.